Table 2.
Serological response from the rBaculovirus-derived RHDV2 VP60 ELISA for the rabbits challenged with RHDV2.
| . | Study Day | Study Day | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Group | Rabbit ID | 0 | 91 | 226 or 227 | Group | Rabbit ID | 0 | 91 | 226 or 227 |
| 1—Vaccinate | 056 | . | . | 1600 | 2—Placebo | 196 | . | . | <200 |
| 179 | <200 | 3200 | 1600 | 267 | . | . | <200 | ||
| 354 | . | . | 800 | 765 | <200 | <200 | <200 | ||
| 361 | . | . | 1600 | 796 | . | . | <200 | ||
| 537 | . | . | 1600 | 972 | <200 | <200 | <200 | ||
| 934 | . | . | 800 | 0D7 | <200 | <200 | <200 | ||
| 8E5 | . | . | 3200 | 2C6 | . | . | <200 | ||
| 06C | . | . | 800 | 35D | . | . | <200 | ||
| 0AF | . | . | 1600 | 3BC | <200 | <200 | <200 | ||
| 1A4 | <200 | 6400 | 3200 | 6DA | <200 | <200 | <200 | ||
| 20D | . | . | 3200 | B2E | . | . | <200 | ||
| 48A | . | . | 3200 | D4E | <200 | <200 | <200 | ||
| 95E | . | . | 1600 | D81 | <200 | <200 | <200 | ||
| A03 | 200 | 6400 | 1600 | DDB | <200 | <200 | <200 | ||
| A17 | . | . | 3200 | E59 | . | . | <200 | ||
| A8C | <200 | 3200 | 800 | E8B | . | . | <200 | ||
| A94 | <200 | 3200 | 1600 | EC3 | . | . | <200 | ||
| BFD | . | . | 400 | F04 | <200 | <200 | <200 | ||
| C1F | <200 | 1600 | 1600 * | F91 | <200 | <200 | <200 | ||
| C2A | . | . | 6400 | FFC | . | . | <200 | ||
| C80 | <200 | 3200 | 800 | ||||||
| CDE | . | . | 1600 | ||||||
| E73 | . | . | 3200 | ||||||
| EF2 | <200 | 6400 | 1600 | ||||||
| F85 | <200 | 6400 | 1600 | ||||||
| F8B | <200 | 3200 | 800 | ||||||
= No Sample. * = Sample collected on SD 207, prior to rabbit being removed from study for humane reasons. Animal did not enter the challenge phase.